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ABSTRACT 
 
To monitor chemical changes in brain occurring during stress, several rats were put to death 
in both stressed and non-stressed situations. According to age it was desirable to see which 
effects stress constitutes in a rat brain. By using rats as experimental animals, the difference in 
the level of neurotransmitters was studied and compared in a stressed and non-stressed 
situation for different aged rats. 
 
Sample preparation, including solid phase extraction (SPE) on a CBA (carboxy propyl phase) 
weak cation exchanger (WCX) and a reversed phase (RP) C18 column, was initially 
performed on rat brain parts to extract the compounds of interest. The extraction resulted in 
two fractions, A and B, with hydrophobic- and ionic compounds, respectively. 
 
The samples were subsequently analysed using the developed 2D capillary LC method 
employing a strong cation exchanger (SCX) in the first dimension, and a reversed phase C18 
column for focusing and separating the analytes in the second dimension. 50 µL of brain 
tissue extracts were initially loaded and focused on the SCX column and elution was 
performed by a buffered salt step gradient ranging from 20 – 500 mM ammonium formate. 
Subsequently, the fractions were trapped on reversed phase trap columns prior to back flushed 
elution onto the RP analytical column. The separation was conducted using a linear ACN/H2O 
gradient where the mobile phase contained 10mM acetic acid. Detection was performed by an 
electrospray ionization ion trap mass spectrometer (ESI-IT-MSn) in the positive mode. 
 
The experiments proved abnormal activity in a rat brain during stress, and some compounds 
with bigger abundance differences in the stressed and non-stressed occasions were found and 
identified. The system evaluation revealed some fluctuations in the analyte area. With 
angiotensin II as a test substance, the area had an RSD (%) value of 16 % while the retention 
time had a corresponding value of 1 %. 
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ABBREVIATIONS AND DEFINITIONS 
 
µLC    micro liquid chromatography 
ACN    acetonitrile 
BPC    base peak chromatogram 
CBA    carboxy propyl phase 
cLOD    concentration limit of detection 
EIC    extracted ion chromatogram 
ESI    electrospray ionisation 
I.D.    inner diameter 
IT    ion trap 
LC    liquid chromatography 
LOD    limit of detection 
LOQ    limit of quantification 
MeOH    methanol 
mLOD    mass limit of detection 
MS    mass spectrometry 
MS/MS or MS2  tandem mass spectrometry 
O.D.    outer diameter 
Proteomics   the qualitative and quantitative comparison of proteomes under  
    different conditions or further unravel biological processes 
RP    reversed phase 
S/N    signal to noise ratio 
SCX    strong cation exchanger 
SPE    solid phase extraction 
TFA    trifluoro acetic acid 
TIC    total ion chromatogram 
UV    ultraviolet 
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1. Introduction 
 
In this project the analyses were performed on brain tissue extracts from two different main 
groups of rats, dependent on how they were killed. One group was stressed when exposed to 
quick suffocation, while the other group were put to sleep by slow suffocation. The 
suffocation procedure was controlled by high (stress) and low (non-stress) influx of CO2 (g). 
Outer influence affects the psychic state of an individual and can give physical reactions as 
increased heartbeat. A group of compounds existing in brain, neurotransmitters, control all the 
bodily functions in a human being. Depending on the situation, for example during stress as in 
this case, the levels of certain neurotransmitters change.  
 
Neurotransmitters constitute a group of compounds responsible for signal transmission 
between neurons or non-neuronal cells that they innervate. Neurotransmitters play a major 
role in controlling our state of mind and even slight changes in neurotransmitter systems can 
contribute to the development of neurological diseases or brain disorders. Neurotransmitters 
are generally divided into three groups; amino acids, biogenic amines and neuropeptides. In 
this case, neuropeptides from rat brain tissue were the compounds of interest. Due to high 
receptor specificity, neuropeptides are normally found in very small amounts, requiring highly 
sensitive methodology for their determination. Due to the complex nature of the samples and 
the high number of potentially neurotransmitting peptides, high separation power is required 
for their determination. Below it is shown how neurotransmitters are moving from the 
presynaptic neurons to the postsynaptic neurons where the chemical signal is transformed to 
an electrical signal (Fig.1). A more descriptive figure of a neuron’s function is shown in 
appendix 4.3. 
 
 
Fig. 1 Signal transmission between neurons in the synaptic cleft [1] 
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During recent years packed capillary liquid chromatography (LC) has become an important 
tool for analytical purposes, due to several advantages associated with the use of smaller 
dimension columns compared to the conventional size. One important advantage is the 
increased mass sensitivity due to less dilution of the chromatographic band in the column. If 
the same amount of analyte (absolute mass) is introduced into a capillary column and a 
conventional column, the capillary column will have a theoretical mass limit of detection 
(mLOD) approximately 200 times lower than the conventional one (Eq. 1) [2].  
 
Eq. 1: Calculation of dilution in the column 
 
The equation contains parameters where c0 is sample concentration, cmax is final concentration 
at detector, ε is column porosity, r is radius of the column, k is retention factor, L is length of 
column, H is plate height and Vinj is volume injected. In biological analysis there are 
sometimes very small amounts of sample available and it is therefore convenient to use 
miniaturized techniques. Reduction in the consumption of mobile- and stationary phases and 
the possibility to use temperature programming are also benefits of importance. The former 
are of economical and environmental matter, while the latter can be exploited in retention 
control because of the low thermal mass of the capillary columns. Furthermore, the low flow 
rates (down to 1 µL/min) used in capillary LC makes it easier to use solvent evaporation 
based detectors as the mass spectrometer (MS) [3], the Fourier-transform-infrared- 
spectrophotometer (FT-IR) [4] and the evaporative light scattering detector (ELSD) [5].  
 
To maintain the same efficiency in capillary LC as in conventional HPLC, the sample volume 
injected must be smaller and injectors with small internal loops are used. The increased mass 
sensitivity could only be exploited when injecting the same sample volumes as in 
conventional LC. When greater sample volumes are injected, techniques with external loops 
and sample enrichment are required, such as on-column focusing large volume injection or 
column switching systems with on-line solid phase extraction [6-8]. In a switching system the 
sample can be introduced in a non-eluting solvent, and solutes in large volumes can be 
concentrated on the trap column followed by elution through the analytical column without 
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any loss in resolution. These techniques have been used for quantification of peptides and 
proteins at low concentration in biological and environmental samples [9-10].  
 
In recent years two dimensional (2-D) chromatographic systems have been subject to 
increased use in connection with biochemical analyses [11-14]. Combining two techniques 
with different separation principles makes it possible to analyse more complex samples in 
biochemical analyses. Because the separation is performed in two independent dimensions, 
the peak capacity is larger and can be estimated by multiplying the two dimensions peak 
capacities [15-16]. There are two different main techniques in 2-D LC, comprehensive 
chromatography and heart- (/front-/end-) cutting. In the comprehensive approach the entire 
sample is subjected to two different separations, each with different separation characteristics. 
By contrast, in heart cutting only a fraction from the first retention axis is transferred for 
separation on the second dimension axis [15-16]. 
 
Peptide and protein samples often consists of highly complex mixtures where high-resolution 
techniques are essential to get accurate information about their abundance and also, in some 
cases, information about their configuration. In some cases two dimensional systems are 
required to get sufficient resolution, but it has also been performed successful analyses by the 
use of one dimensional systems [17-18]. 2-D polyacrylamide gel electrophoresis (PAGE) has 
been the main separation technique for separation of proteins [19-23], but the last few years 2-
D LC has become a popular supplement to this technique. Anyway, due to the peptides’ low 
molecular weight they cannot be analysed by the use of PAGE [24]; therefore 2-D LC 
becomes a natural choice for peptide analysis. Combinations used in 2-D LC separations are 
reversed phase together with size exclusion chromatography (SEC)-RP [25-26] or strong 
cation exchange (SCX)-RP [27-30], the latter used in this study. In SCX-RP the sample is 
first separated with regard to the components ionic character into different fractions by the use 
of a SCX column and a buffered salt step gradient. The respective fractions from the first 
dimension are then subjected to linear gradient separation on a RP-column in the second 
dimension. The two dimensions of the LC-system used in this study have complementary 
selectivities that are similar to those of 2-D PAGE. Ion-exchange provides separations which 
are roughly equivalent to that of  isoelectric focusing, while reversed-phase chromatography 
provides a quasi-molecular size separation in which retention tends to increase with 
increasing molecular weight. An advantage of this 2-D LC system is the solvent compability 
of the two dimensions; elution solvents utilized for the ion exchanger are weak solvents in the 
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reversed phase system. This leads to refocusing of the chromatographic band when the eluted 
compounds from the first dimension reach the second dimension. Another advantage is the 
compability of the solvents used in reversed phase with electrospray ionization (ESI) [36] and 
Matrix Assisted Laser Desorption Ionization (MALDI) [31-32].  
 
 
1.1 Aim of study 
 
The aim of this study was to develop a miniaturized two-dimensional capillary liquid 
chromatographic (2-D capLC) method for determination of several neurotransmitters (mainly 
neuropeptides) from rat brain tissue extracts. Because of the anticipated very high amount of 
unknown compounds in the samples it was not possible to identify them all. The scope of this 
project was therefore to map the differences between the most abundant compounds and 
determine which neurotransmitters (or neuropeptides) they constituted. From the results it was 
desirable to see, according to age, what effect stress constitutes on the production of 
neuropeptides in a brain. 
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2. Experimental 
 
Six different regions of the rat brain were studied in this experiment; cerebellum, brain stem, 
rhinencephalon, hippocampus, prefrontal cortex and hypothalamus (fig. 2). Samples from the 
two former were used for testing and optimization of the 2-dimensional system. Samples from 
different main group (stressed / not stressed), but from the same brain region, were studied to 
establish the variations between the samples and identify the most abundant compounds.  
 
Fig.2 Illustration of the brain lobes in a human brain [33] 
 
 
2.1 Materials and reagents 
 
All samples which are analysed and represented in the results and discussion section are taken 
from male Wistar rat brains delivered from the Medical University of Gdansk (Gdansk, 
Poland). Grade 1 water used to prepare mobile phases was obtained from a Milli-Q ultrapure 
water purification system (MilliPore, Bedford, MA, USA). HPLC grade acetonitrile (ACN) 
was purchased from Rathburn Chemicals Ltd. (Walkerburn, UK). Ammonium acetate (98%),  
formic acid (50%) and gradient grade water used in mobile phases for the real sample runs 
were purchased from Fluka (Buchs, Switzerland). Three internal standards were used in this 
experiment; propanolol, ibuprofen and L-Dopa-2,5,6-d3. The two former were purchased from 
Sigma Aldrich (Oslo, Norway) while the third was purchased from C/D/N-Isotopes Inc. 
(Quebec, Canada). The peptides used as test substances, angiotensin II and bradykinin, were 
purchased from Sigma Aldrich. The SPE columns used during sample preparation, Isolute 
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reversed phase C18 and Isolute weak cation exchanger CBA, both with 1 mg sorbent and 1 
mL bed volume, were delivered by International Sorbent Technology (Glamorgan, UK). 
Anopore filters with pore size 0.22 µm used during sample preparation were purchased from 
Anotop IC (Whatman plc, UK). BioBasic SCX stationary phase material with particle size 5 
µm was obtained from Thermo El. Corp. (Cheschire, UK), while the packing material for the 
Partisil SCX-column with particle size 10 µm was obtained from SGE Europe Ltd (Potters 
Lane, UK). The Macrosphere column (10 cm x 0.3 mm I.D.) with particle size 7 µm was 
purchased from G&T SepTech A/S (Kolbotn, Norway). The polysulphoethyl aspartam 
stationary phase used for packing of the strong cation exchanger in first dimension was 
obtained from Teknolab A/S (Kolbotn, Norway). The stationary phase used in the Kromasil 
C18 trap columns (4 cm x 320 µm I.D.) with particle size 5 µm and in the Kromasil C18 
analytical (10 cm x 320 µm I.D.) column with particle size 3.5 µm was purchased from Eka 
Nobel (Bohus, Sweden). The PLRPS polystyrene/divinylbenzene (Polymer Labs, Amherst, 
MA, USA) pre columns (0.5cm x 0.8mm I.D.) with a particle size 5 µm were delivered by 
Teknolab A/S. All fused silica capillaries were obtained from Polymicro Technologies Inc. 
(Phoenix, AZ, USA). 
 
 
2.2 Sample preparation 
 
The rat brain tissues in the mass range 20-450 mg were stored in a Cryo-Exchange Vapor 
Shipper (Taylor-Wharton, Husum, Germany) before and after the sample preparation. 10 µL 
of the three internal standards with a concentration of 1.5 ng/µL were added and are presented 
in table 1. 
 
Table 1 Internal standards and their molecular weights 
Internal standard Mw 
ibuprofen 206.28 gmol-1 
L-Dopa-2,5,6-d3 197.19 gmol-1 
propranolol 259.35 gmol-1 
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The rat brain was homogenized in a 3 mL propylene vial (Brand GMBH, Wertheim, 
Germany) in 0.5 mL 0.02 M ammonium acetate in 70 % acetonitrile and 30 % water. 
Homogenization was performed with a homogenizer (Kontes, New Jersey, USA) with a 
connected glass pistil (Fig. 3a). The procedure lasted exactly one minute, independent of 
sample size. The three internal standards were added before the homogenization started. The 
sample was then centrifuged (Jouan centrifuge, Kebo Lab, Sweden) for ten minutes with a 
speed of 4000 rpm. After the centrifugation the sample consisted of three layers; first layer 
was foam containing remnants from fats and proteins, second layer was liquid consisting of 
solvent with peptides and third layer was solid of mostly fat (Fig. 3b). After centrifugation the 
liquid was decanted from the vial into a 1 mL polypropylene syringe (Omnifix, Braun, 
Germany) (Fig. 3c). Before loading the sample onto two coupled SPE columns, the SPE 
columns was conditioned separately with the same conditioning agents. Two conditioning 
agents were used, first 0.5 mL acetonitrile (ACN) was added, then 1.0 mL of 0.02 M 
ammonium acetate (Fig.3d). During the sample preparation two different solid phase 
extraction (SPE) columns were used, an Isolute reversed phase (C18) followed by an Isolute 
weak cation exchanger (CBA). The sample solution was transferred from the syringe into the 
separation columns through a 0.22 µm filter (Fig. 3e). The columns containing the sample 
solution was stepwise filled with two eluting agents which were pushed through the columns 
with the use of a syringe. The first eluting agent, consisting of 0.02 M ammonium acetate in 
70% acetonitrile, made an A-fraction, while the second eluting agent, consisting of 1.0 M 
formic acid in 50% acetonitrile, made the B-fraction (Fig. 3f). The eluting (0.5mL) and 
washing (0.3mL) procedure was carried out in the same step, that is 0.5mL + 0.3mL = 0.8mL 
total volume of the eluting agent. The two fractions were collected in two 1.5 mL 
polypropylene micro centrifuge tubes (Brand GMBH, Wertheim, Germany), A and B, and 
immediately frozen at -197 °C in a nitrogen dewar.  
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Fig. 3 Flow chart of the sample preparation 
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2.3 Column preparation 
 
Except for the pre columns, all the columns used in this study were capillary columns made 
in-house. Polyimide coated fused silica was utilized as the column body due to this material’s 
robustness and flexibility. As the diameter of the column is decreased, extra-column dead 
volumes become critical with regard to chromatographic performance, and dead volumes 
arising from e.g. connections, tubing cuts, filters, unions etc., were carefully considered and 
minimized. The capillary columns were packed in the laboratory using a  technique where a 
suspension of stationary phase and the non-agglomerating solvent carbon tetrachloride 
introductorily were sonicated to get a homogenized slurry. Subsequently, the slurry was 
transferred to a stainless steel packing chamber connected to a syringe pump containing a 
mobile phase of ACN and water (70/30, v/v). The slurry was pumped through the fused silica 
column body by linearly increasing the mobile phase pressure to 650 bars. The separation 
columns of 320 µm I.D. and 450 µm O.D. were packed in lengths of 5 cm and 10 cm for the 
trap columns and the analytical (both SCX and RP) columns, respectively. Valco ZU1C 
unions in combination with Valco FS1.4 polyimide ferrules and Valco 2SR1 steel screens 
served as column end fittings (Valco Instruments, Houston, TX, USA) in all columns. The 
ferrules used in the column end fittings needed to be enlarged to 450 I.D. in order to fit the 
column O.D.  
 
 
2.4 Chromatographic systems 
 
Before the development of the two dimensional system took place; a temporary system used 
for column testing was set up. Only the strong cation exchanger columns were tested, while 
the choice of reversed phase columns was based on an unpublished report made by Sandra 
Rinne at the University of Oslo [34]. A detailed description of the chromatographic system 
used in the preliminary experiments is given in point 2.4.1 while the 2D-LC system used are 
described in 2.4.2. 
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2.4.1 Column testing system 
 
The µLC-system used for the column testing consisted of an Eldex MicroPro Syringe (Eldex, 
Napa, CA, USA) gradient LC pump, and a Linear UVIS 200-detector from Spectra-Physics 
(Fremont, CA, USA) with an on capillary detection. A Valco Cheminert C4 (Cotati, MO, 
USA) injector valve with an inner loop of  50 nL was used for introduction of the sample. The 
detection was performed at 220 nm. Fused silica capillaries with an inner diameter of 50 µm 
were used to connect all the components in this instrumental setup except from the capillary 
connected between the injector and the detector. Due to the detection window needed in 
combination with the UV-detector the capillary had an inner diameter of 100 µm. 
 
 
2.4.2 Two-dimensional system 
 
The two-dimensional system (fig.4) used for the analysis of the rat brain extracts consisted of 
three pumps, two Eldex MicroPro Syringe gradient LC pumps and one micro LC isocratic 
pump (L-7100, Hitachi, Tokyo, Japan). The valves used were two electronic 10-ports Valco 
Cheminert C2-1030D valves (Vici AG, Valco International, Schenkon, Switzerland) where 
one of them, coupled to an outer loop of  50 µL, was used for introduction of the sample. Both 
the valves were two-position microelectronic valves, but of two different models, model E36-
230 in the first dimension and the faster model EHMA in the second dimension. All the 
components of the 2-dimensional system were connected to the valves with 50 µm I.D. fused 
silica capillaries, except from the pumps that were connected with 75µm I.D. fused silica 
capillaries. Detection was performed by an Esquire 3000+ Ion-Trap Mass Spectrometer (IT-
MS) (Esquire Series, Bruker). 
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Fig.4 Illustration of the two-dimensional system. See text for description of the system. 
 
 
2.4.2.1 Mobile phases 
 
In the 2-dimensional system two different solvent gradients were used; a salt step gradient in 
the first dimension and a linear reversed phase gradient in the second dimension. The salt step 
gradient pump had two solvent reservoirs; reservoir A contained 1 mM ammonium formate in 
10 % ACN with pH adjusted to 3, reservoir B contained 500 mM ammonium formate in 10 % 
ACN with pH adjusted to 3.5. The linear gradient used two solvent reservoirs; reservoir A 
contained 99.9 % water and 0.1 % acetic acid, and reservoir B contained 99.9 % ACN and 0.1 
% acetic acid. An additional isocratic pump (pump 3) with a reservoir containing 99.9 % 
water and 0.1 % TFA was connected between the two dimensions.  
 
 
2.4.2.2 Functionality 
 
The same instrumentation and conditions were used for analyses of both the A- and B- 
fractions, except from the salt step gradient that differed in the two cases (Table 2). The 
sample prepared rat brain tissue extracts were introduced in the system by on-column 
focusing large volume injection. Initially the samples were loaded onto the strong cation 
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exchanger with a weak buffer solution of ammonium formate in 10 % acetonitrile. Further the 
remaining analytes were released from the cation exchanger in fractions by increasing the salt 
concentration stepwise. Each fraction was trapped on one of the two trap columns every other 
time and while the organic linear gradient was back flushing one trap column, the next 
fraction was trapped on the other. Finally, the back flushed analytes from the trap columns 
was transferred to the reversed phase analytical column. The elution on the analytical column 
was performed by the same gradient that back flushed the analytes from the trap-columns. 
The reversed phase linear gradient ranged from 5 to 70 % in 30 min followed by 10 min 
equilibration for each of the fractions from the first dimension. With six fractions from the 
first dimension the total run time for the analyses of B-samples was 255 min, while the five 
fractions from the A-samples had duration of 215 min. After separation in the 
chromatographic system the sample was introduced in an ion-trap mass spectrometer by 
electrospray ionization (ESI). 
 
Table 2a: LC time table for salt step gradient for the A-samples   
  
Time (min): % B: Conc. ammonium formate (mM): Fraction no. 
0.01 – 15 0 1 1 
15.01 – 55 1 5 2 
55.01 – 95 2 10 3 
95.01 – 135 4 20 4 
135.01 – 175 10 50 5 
 
 
Table 2b: LC time table for salt step gradient for the B-samples   
 
Time (min): % B: Conc. ammonium formate (mM): Fraction no. 
0.01 – 15 4 20 1 
15.01 – 55 10 50 2 
55.01 – 95 20 100 3 
95.01 – 135 40 200 4 
135.01 – 175 70 350 5 
175.01 – 215 100 500 6 
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2.4.2.3 Automation 
 
Three actions were done manually in every run; loading of sample, start of pump in first 
dimension and start of acquisition. At the same time the pump in first dimension was started, 
the first valve was automatically triggered by the pump and so injected the sample. After the 
fifteen minutes long injection the first pump triggered the second pump which switched the 
second valve and started the linear gradient. At this moment the data acquisition was 
manually started. Every fortieth minute (after the linear gradient described in previous page) 
the second valve was switched by the linear gradient pump to elute the previous fraction from 
the first dimension. 
 
 
2.4.2.4 Detection 
 
The peptides eluting from the second dimension were detected by an Esquire 3000+ ITMS 
instrument by Bruker Daltonics (Bremen, Germany) equipped with a low-flow nebulizer to 
accommodate flows in the low µl/min range. The ITMS instrument was operated in the 
positive mode with a capillary voltage of 3700 V, end plate offset at 500 V, skimmer at 40 V 
and capillary exit at 128.5 V. Nebulizer and drying gas were applied at 15.0 psi and 6 L/min, 
respectively, in order to enhance mobile phase evaporation and spray stability. Data was 
acquired in the m/z range 250 – 2000 using the Esquire Control v 3.5 by Bruker Daltonics 
both in the MS mode and in the Auto MS(n) mode. Determination of the compounds was 
performed by fragmenting the most abundant compounds in the ITMS. Fragmentation was 
only performed on compounds with a higher intensity than a preset threshold value that was 
decided by experimental trials. Two injections from each sample were performed, the first in 
single MS mode and the second in auto MS (MS/MS) mode. The single MS run was used to 
define the most abundant compounds while the corresponding fragment line spectra of the 
compound masses in the auto MS run was used for identification. The identification was 
performed by exporting one of the abundant peaks’ fragment spectrum from Esquire Control 
into BioTools software followed by a MS/MS online search with the Mascot search engine 
from Matrix Science. The fragment spectrum was then compared with hypothetical fragment 
spectrums of peptides virtually derived from a limited amount of the proteins in the database 
at the National Center for Biotechnology  Information (NCBInr). The search was limited by 
choosing a specific taxonomy, in this case mammals.  
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3. Results and discussion 
 
Even though a two-dimensional system with high resolving power was used in this project, 
offline sample preparation was necessary to finally get sufficient resolution. Also, since the 
samples was solid brain tissue at the starting point, some extraction was necessary to get the 
analytes into an injectable liquid at the same time as enzymatic degradation needed to be 
reduced.  
 
 
3.1 Sample preparation 
 
In order to reduce the enzymatic degradation that always will take place to some extent during 
extraction, the tissue was homogenized/extracted with 70% ACN and then centrifuged, which 
is expected to halt further degradation. Due to the high concentration of acetonitrile in the 
sample none of the hydrophobic analytes were retained on the C18 column during the 
application, but rather eluted straight through the column. The reason for the C18 column to 
be there was to remove most of the fat in the sample. The fat has a very great retention on a 
C18-column and 70 % acetonitrile in the eluting agent assures the extraction of the more 
hydrophobic peptides, while at the same time extracting only a minor part of the fat of the 
brain tissue, as seen by a fatty residue which was removed by centrifugation. Consequently, 
the hydrophobic analytes/compounds were eluted through both the columns from the very 
beginning; while the ionic compounds were retarded on the CBA-column until the second 
eluting agent (formic acid in ACN) was added. Due to the 0.02 M ammonium acetate in the 
first eluting agent, weak cationic compounds could also elute in this fraction. Because the 
analytes in the A-fraction only are slightly ionic, the steps used for the A-fraction in the 
chromatographic systems step gradient are smaller than for the B-fractions.  
 
 
3.2 Column testing 
 
Three different SCX-columns were initially tested before the final 2-D LC system was put 
together; Partisil SCX (10cm x 0.32mm I.D., 10µm), Macrosphere SCX (10cm x 0.5 mm I.D., 
7µm) and BioBasic SCX (10cm x 0.32mm I.D., 5 µm). All the SCX-columns required the 
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same amount of acetonitrile to avoid secondary interactions, and it was found that 20 % 
acetonitrile was requisite to make the analytes elute through the ion-exchange column (fig.5). 
To avoid break through on the trap-columns that concentrates the components in all the 
fractions from the first dimension, it was necessary to have only a few percent of acetonitrile 
in the mobile phase entering the RP trap-column. None of the tested SCX columns obtained 
good efficiency with an amount of 5 % ACN, but a later tested column, PolySulphoEthyl A, 
required only 10 % acetonitrile in the mobile phase to elute the compounds. This packing 
material was therefore used in the further study. The amount of ACN needed was still too 
large to focus the analytes on the trap columns inlet, and therefore a dilution pump was added 
to the system between the two dimensions. The dilution pump gave a flow twice the flow of 
the buffered salt step gradient pump (20 µL/min) which made a three times dilution of the 
mobile phase. 
  
 
 
Fig. 5 With 0.5M ammonium chloride the analyte (AngII) elutes fast through the BioBasic SCX column 
but with big differences in efficiency according to the percentage of acetonitrile. a) 20%, b) 15%, c) 10%. 
 
It was desirable to avoid the use of a diluting step between the two dimensions to decrease the 
instrumentation’s complexity. Several different parameters were changed to make the analytes 
elute through the BioBasic SCX column by using only five percent acetonitrile: The pH of the 
mobile phase was first changed from pH 4 to pH 3 to make sure that the compounds had a 
total positive charge. The same was done with the sample solution to be sure that the analytes 
was not locally deionised, but no improvement was observed. A change in flow from 8 to 10 
µl/min was performed to get faster elution and narrower peaks, but still no improvement. 
Mobile phases containing different buffer solutions were tested with the system, without any 
improvement in peak shape. NaCl had too weak eluting strength, and formic acid absorbed 
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too much UV-radiation. Ammonium chloride that has average eluting strength [35] and 
approximately no UV-absorption by 220 nm was used for the final testing of the SCX-
columns. 
With respect to the retention factors relatively large differences between the different reversed 
phase columns have been obeserved. As mentioned the RP columns were tested by others [34] 
and the conclusion was that the best efficiency was obtained by the Kromasil C18 material. 
 
 
3.3 System evaluation 
 
The 2-dimensional system used in this project was comprehensive with regard to the strong 
cation exchanger that fractionates the sample in the first dimension and the reversed phase 
column in the second dimension. The first dimension was originally planned to be a buffered 
salt step gradient with a pH of 3, but due to high buffer capacity this low level was not 
attainable in the B reservoir. The final system therefore also involved a small pH gradient 
from pH 3 (reservoir A) to pH 3.5 (reservoir B) in the first dimension. To get higher retention 
and better focusing on the C18 trap columns the analytes interacted with the ion-pairing agent 
TFA from the dilution mobile phase before reaching second dimension (Fig. 2). Unfortunately 
TFA interacts so strong with the analytes that it could cause ion-suppression in the MS [36], 
but this case was avoided by back flushing the analytes with the RP mobile phase containing 
acetic acid. Acetic acid makes weaker interactions with the analytes than TFA and simplifies 
ionization in the electrospray. As mentioned earlier the extent of ionization is also much 
affected by the mobile phase composition, and use of the combination water with acetonitrile 
and acetic acid fulfils the electrospray’s demand for volatility [37]. 
 
Previous projects regarding peptides have shown that acetonitrile is a solvent that greatly 
elutes peptides from a C18 stationary phase [38], and so acetonitrile was chosen as organic 
modifier in the second dimension. To obtain the best efficiency both duration and 
composition of the organic linear gradient were changed several times during the method 
optimization. Further, refocusing on the analytical column in the second dimension was 
achieved by using bigger particle size in the trap columns (5 µm) than the particle size in the 
analytical column (3.5 µm).  
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Due to all the parts in the system that must interact properly, the method development was a 
time consuming process. Samples from brain stem and cerebellum was used as test samples as 
it was expected to find fewer compounds linked to stress/non-stress in these brain regions 
compared with the other brain regions. None of the compounds in the test samples was 
identified, but the test samples were rather used for optimisation of the fractionation and 
separation of the compounds.  
 
The total ion chromatogram (TIC) (Fig. 6a) was not used for quantification of any 
compounds, but it was used as a normative measurement for the system stability by ensuring 
that the baseline trend looked the same in every fraction in the no-injection run. By studying 
the base peak chromatogram (BPC) from a no-injection run (Fig. 6b) it was possible to decide 
which peaks originated from the system (mobile phases, stationary phase bleeding, couplings, 
gradient effects etc). The start of every linear gradient is marked with arrows and acquisition 
duration in minutes in the BPC. 
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 Fig. 6a Total Ion Chromatogram (TIC) from a no-injection run 
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Fig. 6b Base Peak Chromatogram (BPC) from a no-injection run. Arrows mark start of every RP 
gradient. Numbers are runtime. 
 
Due to polyethylene glycols (PEG’s) in the mobile phase water, a very high background was 
observed in the first runs with the final system. By changing the mobile phase water from 
MilliQ- to HPLC grade- water, and adding polystyrene divinylbenzene (PS-DVB) pre 
columns to the dilution pump and the salt buffer gradient pump, the background was 
significantly reduced. Other compounds with origin in the organic mobile phase also 
contribute to the background, but these compounds were not identified. In the single MS run 
the interfering agents are negligible, but during the auto MS run they could make problems 
because of their high intensity. However, since the masses were known they were registered 
in the MS-software so even though their intensity exceeded the threshold value, MS/MS was 
not performed on them. The zoomed fraction in the BPC from the no-injection run (Fig.7) 
shows the background peaks that occur in every fraction. The first eight masses are PEG’s 
while the last masses are unidentified.  
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Fig. 7 Zoom of BPC from one of the no-injection fractions showing the background masses 
 
The greatest challenge in this project was sequencing of the compounds of interest. It was not 
known in advance which compounds that could exist in the matrix, and the use of standard 
solutions to compare with was therefore excluded. Also, normally when working with 
biological samples containing amino acid sequences, the molecule (mostly proteins) has 
reacted with a known enzyme that cleaves the amino acid sequence at specific positions in the 
chain. After the fragmenting is done with the mass spectrometer the data analysis software is 
fed with what kind of enzyme the analytes was treated with. This information gives the 
database search algorithm a hint which limits the amount of possible structures the analyte 
could have. When the database search is finished, the software suggests which compound the 
analyte is most likely to be. The suggestions are represented as “hits”, which gives 
information about the structure and the possibility for the respective structure. 
In the current case, the hint is absent because the sample is not treated with any kind of 
enzyme. Consequently, the search can not be narrowed down and suggested possible 
structures for every compound is considerably increased.  
 
During the MS fragmentation procedure the point of cleavage can be located in several 
positions in the chain, both in the backbone and the sidebone. However, it is most likely that 
the cleavage finds place between the C- and N- terminal of two amino acids, known as the 
peptide bond. The part that follows the N-terminal from the precursor ion is called the y-
fragment while the other part belonging to the original C- terminal is called the b-fragment 
(Fig. 8). The nomenclature for naming such fragments is described in detail by Michael 
Kinter and Nicholas E. Sherman [40].  
388.2  432.2  476.4  520.4  564.5  608.5  652.5  696.6
345.3
373.4 
288.2 
PEG’s (∆m = 44.0) 
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Fig. 8 Fragmentation of an amino acid sequence 
 
To prove the reliability of the Mascot search algorithm, a complete example of how 
identification of a known compound (Bradykinin) was performed is shown in appendix 5.3. 
 
 
3.3.1 Internal Standards 
 
Due to different reasons two of the three internal standards added to the samples during the 
sample preparation could not be used in the analyses. After optimization of the instrument 
parameters, the scanning range was starting on m/z = 250 which is beyond the m/z-value of 
ibuprofen (Mw = 206.28 gmol-1) and L-dopa-2,5,6-d3 (Mw = 197.19 gmol-1). In addition L-
dopa-2,5,6-d3 have no retention on the trap columns and will elute to waste. Therefore only 
propranolol (Mw = 259.35 gmol-1) was useful as an internal standard. As can be seen from the 
extracted ion chromatogram (EIC) below (Fig. 9) propranolol appeared mainly in the first 
fraction, but a small signal is also visual in the second fraction.  
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Fig. 9 The peak from the internal standard propranolol in the extracted ion chromatograms from both the 
stressed (upper) and non-stressed (lower) samples 
 
 
3.3.2 Repeatability 
 
To prove the systems repeatability the peptide angiotensin II was used as test substance. The 
repeatability testing was performed by four injections of the test sample in a concentration of 
20 ng/ml (1 ng absolute mass) with the same system conditions as used with the real sample 
runs. The within day results from the four injections are given in the figure below (Fig. 10), 
while the statistical values regarding retention time and areas are represented in table 4. As 
can be seen from the figure and table below, intensity fluctuations occurred during the day of 
repeatability testing. Of unknown reasons the signal decreased even though the concentration 
of the test substance was the same. The in-house conclusion was that the error originated in 
the mass spectrometer, and this theory was strengthened by other users which also have 
reported high RSD values in connection with the mass spectrometer [41-42].  
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Fig. 10 Overlaid chromatogram of the four injections of Angiotensin II performed with the final 2-D LC 
system.  The analyte was eluted in the first salt step fraction. 
 
Table 4: Repeatability testing results 
Replicate no. (x) Rt area 
1 5.6 38540876 
2 5.8 45590527 
3 5.9 47072893 
4 5.9 33125626 
xave 5.8 41082481 
σx 0.0577 6480196 
RSD (%) 0.995 16 
 
 
3.3.3 Limit of detection 
 
The limit of detection was defined as three times the noise (S/N = 3). With a 50 µL loop the 
lowest solution concentration obtained, according to the definition, was 1 ng/mL with a 
corresponding absolute mass of 50 pg. The results are shown in table 5 and figure 11. 
 
Table 5: Limit of detection 
Inj nr RT [min] Area 
1 5.3 12317682 
2 4.9 9480197 
3 5.1 7648713 
Ave 5.1 9815531 
STDEV 0.2 2352478 
RSD (%) 3.921569 23.9669 
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Fig. 11 Chromatograms of the three injections from the determination of limit of detection with 
angiotensin II 
 
From this result it is possible to estimate the smallest amount of analyte that must be present 
in the rat brain tissue to be detected. The final sample volume after sample preparation was 
approximately 150 µL and with a concentration equal to the LOD (1 ng/mL) the absolute 
mass would have been 150 pg. With an average mass of the brain tissue samples of 35 mg this 
concentration corresponds to 4.3 ng analyte per gram brain tissue. 
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3.4 Analysis of rat brain tissue samples 
 
In contrast to the TIC, the BPC was important when determining the relative abundance of 
analytes in the samples from the stressed and non-stressed rats. The BPC monitored the most 
abundant m/z-value at any time, and the value was used to decide which analyte that should be 
further investigated. Figure 12 shows an overview chromatogram from hypothalamus which 
represents a stressed rat (blue line) and not stressed rat (green line) overlay. The arrows points 
at peaks where big differences are visual. 
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Fig. 12 Overlay of two chromatograms from rats exposed to stress (black) and not exposed to stress (pink). 
Arrows marks the most visual differences in this overview chromatogram. 
 
The zoom of the 20 mM fraction from hypothalamus (Fig. 13) shows an overlay 
(“fingerprint”) of a stressed rat (green line) and a non-stressed rat (blue line). The intensity 
differences are evident! There is a little time delay between the two runs and therefore two red 
arrows are marking the respective peak in both two fractions. The red marked peak was one of 
the further investigated peaks due to abundance differences in the stressed and non-stressed 
fraction. As an example the mass spectra of this compound are shown below, while the peaks’ 
profile spectrum before and after fragmentation are presented in figure 14a and 14b, 
respectively. 
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Fig. 13 Zoomed BPC overlay of the 20 mM fractions from stressed (green line) and non-stressed (blue 
line) rats 
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Fig. 14a Mass spectrum showing the parent ion chosen by the software (through the threshold value) to be 
fragmented. Red spot is ion chosen by the software to be fragmented. 
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Fig. 14b Mass spectrum showing the daughter ions from the fragmented parent ion (Blue spot is where 
parent ion was before fragmentation) 
 
Three compounds were tentative identified in this study. Every search in the NCBInr database 
returned a list of suggested compounds that could match the inquired compound. The 
suggestions were ranged after a score which described how much of the analyte amino acid 
sequence the respective suggestions covered. 
 
The compounds with highest score for each of the three inquired compounds in the database 
are shown in the table 6. All the three compounds had a sequence coverage of 100%, and this 
is an often occurring result with small compounds as peptides. Bigger proteins seldom have a 
sequence coverage as good as 100 %, but rather in the range from 30-80 % [39]. 
 
Results represented in the field of proteomics by Per Andrèn and his co-workers show 
promising results where several peptides are found in the same kind of matrix as used here 
[17-18], even though they have only used one-dimensional separation techniques.  
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Table 6: The three tentative identified compounds    
 
m/z-value Charge Retention time Compound name 
Amino Acid 
sequence 
622.8 2+ 6.9 
SOMATOSTATIN-
28 
 
 
SANSNPAMAPRE
 
542.7 1+ 8.9 
OLIGOPEPTIDE 
NO.15.- vectors. 
 
PLVTL 
 
568.3 1+ 18.3 
CYTOCHROME 
OXIDASE II 
(FRAGMENT).- 
Pseudoregma 
koshunensis 
(Bamboo aphid). 
 
MTWM 
 
 
 
3.5 Future plans 
 
Even though the method development in this project is finished and the analysing conditions 
are optimized, there are still several samples left to be analysed. Further work will be based 
on continued identification of the most abundant compounds in the samples and find 
additional results that describe the brain's activity during stress. The connection between age 
and how stress is handled is also an area of interest. 
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4. Conclusion 
 
The method development was a time consuming and challenging task. After optimizing the 
different parts of the system one by one, the most demanding work was to make all the 
components in the system work properly together. Anyway, the current system has shown 
good functionality and high resolution power and is ready for the analyses that will be 
performed in the future.  
 
As mentioned Per Andrèn and his group obtained identification of several peptides by the use 
of a not so complex separation technique as employed in this study. Unfortunately some work 
still remains in this project before comparison with others results can be done.  
 
It would have been preferred to have a fully automized system, but due to different 
manufacturers the components cannot communicate. Anyway, with run times as long as in the 
present system (beyond four hours), an autosampler would have been a great addition to 
exploit the systems capacity. 
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6. Appendix 
 
6.1 The function of a neuron 
 
A neuron activates by transmitting electrical signals along its axon (Fig. 15). When the signal 
reaches the end of the axon, pouches called vesicles are influenced by the electrical signal and 
releases neurotransmitters. Neurotransmitters bind to receptor molecules on the surface of 
adjacent neurons. The area of virtual contact is known as the synapse (as earlier shown in Fig. 
1). 
                                           
 
              
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 15 The function of a neuron 
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6.2 Identification of bradykinin 
 
To ensure the Mascot databases’ reliability, bradykinin was analysed and identified by the use 
of Mascot online database. The arrowed peak below exceeded the preset threshold value and 
MS/MS was performed. Since bradykinin occurs with three different charges, three m/z-
values are found in connection with this peak (Fig. 16). The mass spectra’ are shown in figure 
17. 
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Fig. 16  BPC of bradykinin from the first salt step fraction 
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Fig. 17a  MS spectrum showing the singly charged parent ion chosen to be fragmented  
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Fig. 17b  MS/MS spectrum showing daughter ions from the fragmented parent ion with m/z-value 
1060.656  
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Fig. 17c  MS spectrum showing the doubly charged parent ion chosen to be fragmented  
 
 
 
 
254.054
452.667
522.177
642.226
710.301
807.393
904.472
1001.493 1456.830
2. +MS2(531.065), 10.3-10.8min (#400-#418)
0.0
0.5
1.0
1.5
2.0
5x10
Intens.
400 600 800 1000 1200 1400 1600 1800 m/z  
Fig. 17d  MS/MS spectrum showing daughter ions from the fragmented parent ion with m/z-value 530.916  
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Fig. 17e  MS spectrum showing the triply charged parent ion chosen to be fragmented  
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Fig. 17f  MS/MS spectrum showing daughter ions from the fragmented parent ion with m/z-value 345.269 
 
The best fragmentation pattern (with most daughter ions) was obtained with the doubly 
charged parent ion (Fig. 17d) and this was therefore used in the database search. The figure 
below (Fig. 18) shows the annotation of the profile spectra performed by the BioTools 
software before the database search. Here, two sequences are painted, depending on if the 
starting point is at the N- (y) or C- (b) terminal. The one letter code and other symbols for the 
amino acids are presented in appendix 6.3. 
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Fig. 18 Annotation of the profile spectrum from the fragmented (doubly charged) parent ion. 
 
 
The return of the search is first displaying a “Probability Based Mowse Score” (Fig. 19), 
which is a histogram presenting the number of hits and the hits’ individual score.  
 
 
Probability Based Mowse Score 
 
 
Fig. 19 Probability Based Mowse Score. Ions score is -10*Log(P), where P is the probability that the 
observed match is a random event. Protein scores greater than 74 are significant (p<0.05). 
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Further the index list of suggested compounds is listed by decreasing score.  
 
Table 7 Index. A list of the hits with the highest score 
 
Index         
         
  Accession Mass Score   Description     
1  A61363   1060 46   bradykinin - common frog   
2  S65433   1060 46   bradykinin - horn fly (fragment)   
3  E972904   1188 43 
  KALLIDIN (DEKAPEPTIDE , INTERMEDIATE PEPTIDE) 
  - unidentified. 
4  E977704   1180 42   OLIGOPEPTIDE.- vectors.   
5  A61365   1336 42   phyllokinin - Rohde's leaf frog   
6  S13279   1260 42   Ile-Ser-bradykinin - human (fragment)  
7  E972905   1299 42 
  ARTIFICIAL KALLIDIN FRAGMENT FROM PATENT  
  EP0207402.- unidentified. 
8  A61360   1345 40   vespakinin M - hornet (Vespa mandarinia)  
9  A61359   1343 40   vespakinin X - hornet (Vespa xanthoptera)  
10  E972907   1299 40 
  PROTEIN SEQUENCE 5 FROM PATENT NUMBER  
  EP0207402.- unidentified. 
 
 
By following the link A61363 from the top of the list information about (amino acid) 
sequence coverage is displayed. 
 
 
Table 8 The sequence of the hit with the highest score (bradykinin – common frog) is displayed  
 
No enzyme cleavage specificity  
Sequence Coverage: 100%  
    
Matched peptides shown in Bold Red 
    
     1 RPPGFSPFR   
 
 
Since the hit with highest score was the same as the injected compound (bradykinin), the 
Mascot database functions as expected. 
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6.3 Amino acids and their symbols 
 
Table 9 Formulas and molecular weights  
 
Formulas and Molecular Weights      
          
Table A-1 Amino acid residue masses (mono-isotopic and average)  
together with 3- and 1-letter code and elemental composition  
          
Name Symbol S. C H N O S
Monoisotopic  
Mass 
                        Averaged 
                        Mass 
Alanine Ala A 3 5 1 1 0 71,03712 71,079
Cysteine Cys C 3 5 1 1 1 103,0092 103,145
Aspartic acid Asp D 4 5 1 3 0 115,027 115,089
Glutamic acid Glu E 5 7 1 3 0 129,0426 129,116
Phenylanaline Phe F 9 9 1 1 0 147,0684 147,177
Glycine Gly G 2 3 1 1 0 57,02146 57,052
Histidine His H 6 7 3 1 0 137,0589 137,141
Isoleucine Ile I 6 # 1 1 0 113,0841 113,159
Lysine Lys K 6 # 2 1 0 128,095 128,174
Leucine Leu L 6 # 1 1 0 113,0841 113,159
Methionine Met M 5 9 1 1 1 131,0405 131,199
Asparagine Asn N 4 6 2 2 0 114,0429 114,104
Proline Pro P 5 7 1 1 0 97,05277 97,117
Glutamine Gln Q 5 8 2 2 0 128,0586 128,131
Arginine Arg R 6 # 4 1 0 156,1011 156,188
Serine Ser S 3 5 1 2 0 87,03203 87,078
Threonine Thr T 4 7 1 2 0 101,0477 101,105
Valine Val V 5 9 1 1 0 99,06842 99,133
Tryptophan Trp W # # 2 1 0 186,0793 186,213
Tyrosine Tyr Y 9 9 1 2 0 163,0633 163,176
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6.4 Instrumental settings in the mass spectrometer 
 
 
 
 
 
 
 
 
 
 
 
5.5 Poster presented at the 15. Norwegian Symposium in Sandefjord 
 
 
 
 
 
 
 
Fig. 20a: MS-conditions (MSn page) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 20b: MS-conditions (Tune page) 
 
